ISRCTN11914537已完成未知
Tumour localization and sentinel lymph node identification using a magnetic localisation marker (Magseed) and super paramagnetic iron oxide nanoparticles (SiennaXP): The randomised MagTotal trial
ppsala University0 个研究点目标入组 426 人开始时间: 2018年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 426
研究概览
简要总结
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38150215/ (added 28/12/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Aged 18 years or older
- •2. Ductal carcinoma in situ (DCIS) or invasive breast cancer requiring localisation planned for primary surgery including sentinel node biopsy
排除标准
- •1. Intolerance or hypersensitivity to iron or dextran compounds or Sienna XP
- •2. Iron overload disease
- •3. Pacemaker or other implantable device in the chest-wall, or prosthesis in the shoulder
- •4. Deprived of liberty or under guardianship
- •5. Pregnant or lactating
- •6. Inability to provide informed consent
研究者
相似试验
Enrolling By Invitation
1 期
Sentinel lymph node mapping and ultrastaging in patients with early stage cervical cancerEarly stage cervical cancer (stage IA2-IIA)Early stage cervical cancer, sentinel lymph node, ultastagingTCTR20210314002/A23
尚未招募
Unknown
Mapping lymphatic drainage patterns in recurrent oral cavity squamous cell carcinoma using sentinel lymph node biopsy.CTRI/2024/05/067253I
尚未招募
不适用
Sentinel lymph node mapping in early stage endometrial cancer.ACTRN12618000958280Dept. Of Gynaecological Oncology Mater Adults Hospital350
终止
不适用
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaStage I Cervical CancerCervical Squamous Cell CarcinomaNCT00070317Gynecologic Oncology Group102
已完成
不适用
Detection of sentinel lymph node metastases in endometrial cancer: Performance evaluation of the OSNA assayEndometrial cancerJPRN-UMIN000018083Tohoku University Hospital240